Can I read Semaglutide and NAION Risk Study on EtoBox?

Semaglutide and NAION Risk Study by Driri is a document available to read on EtoBox.

What is Semaglutide and NAION Risk Study about?

This multinational cohort study investigated the association between semaglutide and the risk of nonarteritic anterior ischemic optic neuropathy (NAION) among individuals with type 2 diabetes mellitus (T2DM) or obesity. The results indicated that semaglutide was not associated with an increased risk of NAION across various patient groups, suggesting that concerns regarding NAION should not deter its use given its benefits for blood glucose control and cardiovascular health. The study analyzed data from over

Author

Driri

Language

EN